8 Apr 2024 Date | | - Cons. EPS | - EPS |
20 Nov 2023 Date | | - Cons. EPS | - EPS |
31 Dec 2016 Date | | - Cons. EPS | - EPS |
31 Aug 2016 Date | | - Cons. EPS | - EPS |
31 May 2016 Date | | - Cons. EPS | - EPS |
8 Apr 2024 Date | | - Cons. EPS | - EPS |
20 Nov 2023 Date | | - Cons. EPS | - EPS |
31 Dec 2016 Date | | - Cons. EPS | - EPS |
31 Aug 2016 Date | | - Cons. EPS | - EPS |
31 May 2016 Date | | - Cons. EPS | - EPS |
Food Distribution Industry | Consumer Defensive Sector | Mr. Quanzhong Lin CEO | OTCQB Exchange | US0096033099 ISIN |
US Country | 207 Employees | - Last Dividend | 28 Oct 2020 Last Split | - IPO Date |
AiXin Life International, Inc. is a corporation operating out of the People's Republic of China, primarily focused on the development, manufacturing, marketing, and sale of healthcare and nutritional products alongside wellness supplements. The company integrates traditional Chinese health remedies and modern wellness trends through a diversified business model, encompassing Advertising and Products, Pharmacies, Hotels, and Manufacture and Sale segments. Its sales strategy is broad, leveraging pharmacies, sales offices, direct marketing, online platforms, exhibition events, and conferences to reach consumers. Additionally, AiXin Life International, Inc. extends its market presence through advertising and marketing services and operates AiXin Shangyan Hotel along with retail pharmacies in Chengdu City, enhancing its footprint in the wellness and health sector in China.